CVS Health Corp banner

CVS Health Corp
XETRA:CVS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
XETRA:CVS
Watchlist
Price: 66.31 EUR Market Closed
Market Cap: €85B

EV/IC

0.8
Current
17%
More Expensive
vs 3-y average of 0.7

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.8
=
Enterprise Value
€143.8B
/
Invested Capital
$183.6B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.8
=
Enterprise Value
€143.8B
/
Invested Capital
$183.6B

Valuation Scenarios

CVS Health Corp is trading above its 3-year average

If EV/IC returns to its 3-Year Average (0.7), the stock would be worth €56.59 (15% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-15%
Maximum Upside
+127%
Average Upside
45%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 0.8 €66.31
0%
3-Year Average 0.7 €56.59
-15%
5-Year Average 0.7 €59.04
-11%
Industry Average 1.9 €150.66
+127%
Country Average 1.5 €117.27
+77%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

Lower than 81% of companies in the United States of America
Percentile
19th
Based on 11 657 companies
19th percentile
0.7
Low
0 — 0.9
Typical Range
0.9 — 2.9
High
2.9 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 0.9
Median 1.5
70th Percentile 2.9
Max 566 432.7

CVS Health Corp
Glance View

CVS Health Corporation stands as a pivotal player in the healthcare landscape, tracing its roots back to the early 1960s as a modest chain of health and beauty stores. Evolving through strategic acquisitions and visionary leadership, it burgeoned into one of America’s foremost health solutions providers. The company operates through several segments, each contributing to a comprehensive healthcare ecosystem. Retail/LTC, its retail division, oversees a vast network of pharmacies nationwide, capitalizing on its trusted brand to serve millions of customers with prescriptions, over-the-counter medications, and everyday essentials. Through this extensive reach, CVS leverages its convenience and accessibility, capturing a significant share of consumer healthcare spending. However, CVS's business model doesn't stop at retail. It delves deeper into healthcare through its pharmacy benefits manager, Caremark, which provides employers and insurers with effective cost control for prescription drugs. Additionally, the landmark acquisition of Aetna, a leading health insurer, marked a strategic pivot towards vertically integrated healthcare services. This acquisition has enabled CVS not only to offer insurance products but also to streamline care with initiatives like MinuteClinics and HealthHUBs, aiming to reduce overall healthcare costs while improving patient outcomes. By intertwining its various services, CVS Health positions itself as a pioneer in the industry, standing at the intersection of healthcare delivery, pharmacy services, and insurance management, ultimately crafting synergies that aim to redefine the future of consumer health engagement.

CVS Intrinsic Value
126.66 EUR
Undervaluation 48%
Intrinsic Value
Price €66.31
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett